Dermavant Sci Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DERMAVANT SCI, and what generic alternatives to DERMAVANT SCI drugs are available?
DERMAVANT SCI has one approved drug.
There are nine US patents protecting DERMAVANT SCI drugs.
There are sixty-seven patent family members on DERMAVANT SCI drugs in thirty-six countries.
Summary for Dermavant Sci
| International Patents: | 67 |
| US Patents: | 9 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Dermavant Sci
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dermavant Sci | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 11,597,692 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Dermavant Sci | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 11,612,573 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dermavant Sci | VTAMA | tapinarof | CREAM;TOPICAL | 215272-001 | May 23, 2022 | RX | Yes | Yes | 10,426,743 | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
